Low levels of somatostatin in human CSF mark depressive episodes.
Somatostatin-like immunoreactivity was measured in the cerebrospinal fluid (CSF) of 85 inpatients with current or recent episodes of major depressive disorders, diagnosed according to Research Diagnostic Criteria (RDC) as assessed with the Schedule for Affective Disorders and Schizophrenia (SADS). Several biopsychiatric tests were run during the same week of investigation. Results indicate low levels of CSF somatostatin to be a state marker for episodes of depression characterized by sad appearance, feelings of tiredness, insomnia, and subjective inability to acknowledge any external precipitants for the depression. CSF somatostatin was negatively related to platelet monoamine oxidase (MAO) activity; MAO activity appeared to account better for the degree of melancholic features than did somatostatin. The ratio between 3-methoxy-4-hydroxyphenylglycol (MHPG) and homovanillic acid (HVA) in CSF also correlated negatively with somatostatin. A positive relationship was noted between CSF xanthine and somatostatin. There was a highly significant curvilinear correlation between CSF somatostatin and serum TSH concentrations, but no correlations between CSF somatostatin and serum GH or prolactin, or with plasma cortisol before or after dexamethasone.
D001792:Blood Platelets / Q000201:enzymology; D003866:Depressive Disorder / Q000097:blood / Q000134:cerebrospinal fluid* / Q000523:psychology; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008995:Monoamine Oxidase / Q000097:blood; D011569:Psychiatric Status Rating Scales; D013004:Somatostatin / Q000134:cerebrospinal fluid*; D013972:Thyrotropin / Q000097:blood; D019820:Xanthine; D014970:Xanthines / Q000134:cerebrospinal fluid
D014970:Xanthines; D019820:Xanthine; D013004:Somatostatin; D013972:Thyrotropin; D008995:Monoamine Oxidase; D006854:Hydrocortisone